X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (638) 638
Publication (212) 212
Conference Proceeding (5) 5
Book Review (4) 4
Patent (4) 4
Book Chapter (3) 3
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (300) 300
index medicus (250) 250
oncology (220) 220
male (163) 163
female (159) 159
middle aged (156) 156
glioblastoma (149) 149
adult (144) 144
aged (127) 127
clinical neurology (118) 118
brain neoplasms - drug therapy (101) 101
cancer (101) 101
brain neoplasms - pathology (87) 87
article (78) 78
glioblastoma - drug therapy (78) 78
glioma (73) 73
glioblastoma - pathology (70) 70
survival (68) 68
gliomas (65) 65
prognosis (64) 64
treatment outcome (64) 64
tumors (64) 64
glioblastoma multiforme (63) 63
bevacizumab (62) 62
magnetic resonance imaging (61) 61
temozolomide (60) 60
brain tumors (52) 52
brain neoplasms - mortality (51) 51
medicine & public health (51) 51
animals (50) 50
brain neoplasms - genetics (49) 49
brain neoplasms - therapy (48) 48
glioblastoma - genetics (46) 46
radiotherapy (46) 46
brain (45) 45
glioma - drug therapy (44) 44
brain neoplasms - metabolism (43) 43
expression (42) 42
neurology (42) 42
abstracts (41) 41
malignant glioma (40) 40
glioblastoma - metabolism (39) 39
mutation (38) 38
brain neoplasms - diagnosis (37) 37
clinical investigations (37) 37
care and treatment (36) 36
glioma - pathology (36) 36
dacarbazine - analogs & derivatives (35) 35
glioblastoma - mortality (35) 35
neoplasm recurrence, local - drug therapy (35) 35
antineoplastic agents - therapeutic use (34) 34
brain cancer (34) 34
brain-tumors (34) 34
retrospective studies (34) 34
aged, 80 and over (33) 33
chemotherapy (33) 33
glioblastoma-multiforme (32) 32
mri (32) 32
young adult (32) 32
disease-free survival (31) 31
glioblastoma - therapy (31) 31
malignant gliomas (31) 31
research (31) 31
survival rate (31) 31
radiology, nuclear medicine & medical imaging (30) 30
clinical trials (29) 29
high-grade gliomas (29) 29
mice (29) 29
patients (29) 29
analysis (28) 28
angiogenesis inhibitors - therapeutic use (27) 27
cell line, tumor (27) 27
disease progression (27) 27
follow-up studies (27) 27
growth (27) 27
brain neoplasms - diagnostic imaging (26) 26
cell biology (26) 26
surgery (26) 26
adjuvant temozolomide (25) 25
survival analysis (25) 25
antineoplastic combined chemotherapy protocols - therapeutic use (24) 24
angiogenesis (23) 23
therapy (23) 23
gene expression (22) 22
kaplan-meier estimate (22) 22
magnetic resonance imaging - methods (22) 22
phase-ii (22) 22
phase-ii trial (22) 22
signal transduction (22) 22
biomarkers (21) 21
clinical medicine (21) 21
genetic aspects (21) 21
glioma - genetics (21) 21
glioma - mortality (21) 21
medical research (21) 21
trial (21) 21
adolescent (20) 20
antibodies, monoclonal, humanized - therapeutic use (20) 20
medical and health sciences (20) 20
metabolism (20) 20
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 02/2014, Volume 370, Issue 8, pp. 709 - 722
In patients with glioblastoma, the addition of bevacizumab to radiotherapy and temozolomide induction therapy and the use of bevacizumab maintenance therapy... 
CONCOMITANT RADIOCHEMOTHERAPY | MEDICINE, GENERAL & INTERNAL | PHASE-II TRIAL | RECURRENT GLIOBLASTOMA | CLINICAL-TRIALS | MALIGNANT GLIOMAS | QUALITY-OF-LIFE | RESPONSE ASSESSMENT CRITERIA | MULTIFORME | HIGH-GRADE GLIOMA | ENDOTHELIAL GROWTH-FACTOR | Dacarbazine - adverse effects | Dacarbazine - therapeutic use | Humans | Middle Aged | Induction Chemotherapy | Male | Glioblastoma - radiotherapy | Bevacizumab | Young Adult | Dacarbazine - analogs & derivatives | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Brain Neoplasms - mortality | Brain Neoplasms - radiotherapy | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Double-Blind Method | Kaplan-Meier Estimate | Combined Modality Therapy | Brain Neoplasms - drug therapy | Disease-Free Survival | Quality of Life | Aged | Glioblastoma - drug therapy | Glioblastoma - mortality | Dosage and administration | Research | Temozolomide | Drug therapy, Combination | Drug therapy | Glioblastoma multiforme | Nuclear magnetic resonance--NMR | Intravenous administration | Glucocorticoids | Brain cancer | Body weight | Glioblastoma | Radiation therapy | Survival | Patients | Quality of life | Vascular endothelial growth factor | Index Medicus | Abridged Index Medicus | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2017, Volume 35, Issue 21, pp. 2402 - 2409
Journal Article
Seminars in Oncology, ISSN 0093-7754, 12/2011, Volume 38, Issue 4, pp. S11 - S20
Journal Article
Journal Article
Nature Reviews Cancer, ISSN 1474-175X, 04/2015, Volume 15, Issue 5, pp. 302 - 310
As tumours evolve, the daughter cells of the initiating cell often become molecularly heterogeneous and develop different functional properties and therapeutic... 
Brain Neoplasms - genetics | Receptor, Epidermal Growth Factor - genetics | Signal Transduction - genetics | Glioblastoma - genetics | Humans | Genetic Heterogeneity | Care and treatment | Epidermal growth factor | Analysis | Genetic aspects | Diagnosis | Glioblastoma multiforme | Cancer
Journal Article
Neuro-Oncology, ISSN 1522-8517, 01/2013, Volume 15, Issue 1, pp. 4 - 27
Journal Article